During the past decade, ASST Spedali Civili di Brescia - Ematologia conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 9 clinical trials were completed, i.e. on average, 26.5% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 2 clinical trials were completed. i.e. 11.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ASST Spedali Civili di Brescia - Ematologia" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 28 trials, followed by "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 15 trials sponsored, "Hoffmann-La Roche" with 14 trials sponsored, "European Myeloma Network" with 2 trials sponsored and "Fondazione Italiana Sindromi Mielodisplastiche-ETS" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ASST Spedali Civili di Brescia - Ematologia" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 5 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Janssen-Cilag S.p.A." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "ASST Spedali Civili di Brescia - Ematologia" are "Non-Hodgkin's Lymphoma" (5 trials), "Breast Cancer" (4 trials), "Chronic Myeloid Leukemia" (4 trials), "Acute Promyelocytic Leukemia" (3 trials) and "Follicular Lymphoma" (3 trials). Many other conditions were trialed in "ASST Spedali Civili di Brescia - Ematologia" in a lesser frequency.

Most popular intervention types in "ASST Spedali Civili di Brescia - Ematologia" are "Drug" (48 trials), "Other" (6 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Doxorubicin" (5 trials), "Cyclophosphamide" (4 trials), "Rituximab" (4 trials), "Dexamethasone" (3 trials) and "Prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "ASST Spedali Civili di Brescia - Ematologia" are 64 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "ASST Spedali Civili di Brescia - Ematologia". 3 are not yet recruiting, 9 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in ASST Spedali Civili di Brescia - Ematologia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in ASST Spedali Civili di Brescia - Ematologia, 4 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".